Tasly Pharmaceuticals Gets FDA Approval for Acute Ischemic Stroke Cell Therapy Clinical Study
China-based Tasly Pharmaceuticals (SHA: 600535) has announced that it has received approval from the US...
HutchMed to Receive $20 Million Milestone Payment from Takeda for Fruzaqla Sales
China-based HutchMed (China) Ltd (NASDAQ: HCM; HKG: 0013) is poised to receive a USD 20...
Zhejiang Huahai Pharmaceutical Gets New Zealand Approval for Asthma Bispecific Antibody Trial
Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) has announced receiving clinical trial approval in New...
Youcare Pharmaceutical Group Gets NMPA Approval for YKYY015 Phase I Study
China-based Youcare Pharmaceutical Group (SHA: 688658) has announced that it has received approval from the...
Innovent Biologics Reports Q3 2024 Sales Exceeding RMB 2.3 Billion, Up 40% YOY
China-based Innovent Biologics Inc., (HKG: 1801) has announced product sales exceeding RMB 2.3 billion (USD...
CStone Pharmaceuticals’ Sugemalimab Wins UK Approval for NSCLC Treatment
China-based CStone Pharmaceuticals (HKG: 2616) has received marketing approval from the UK Medicines and Healthcare...
Dizal Pharmaceutical’s Q3 2024 Revenues Soar 236% YOY on Strong Product Sales
China-based Dizal Pharmaceutical Co., Ltd (SHA: 688192) has released its financial report for the third...
Amgen Reports Q3 2024 Revenues of USD 8.5 Billion, Marking a 23% YOY Increase
US biotechnology company Amgen (NASDAQ: AMGN) has announced its financial results for the third quarter...
HOB Biotech Group and Sino Biopharmaceutical Ltd Form Strategic Partnership in Allergy Treatments
Jiangsu-based HOB Biotech Group Corp., Ltd (SHA: 688656) has announced a strategic cooperation agreement with...
Sandoz Q3 2024 Sales Boosted by Biosimilars and Generics, Up 12% YOY
Switzerland-based Sandoz (SWX: SDZ) has published its financial statements for the third quarter of 2024,...
Junshi Biosciences Reports Q3 2024 Financials with Revenue Growth and Narrowed Losses
Junshi Biosciences (HKG: 1877; SHA: 688180) has released its financial results for the third quarter...
Chipsscreen Biosciences and Zhejiang Hisun Pharmaceutical End Strategic Partnership for Chiglitazar Launch
China-based Chipscreen Biosciences Co., Ltd (SHA: 688321) has reached an agreement with Zhejiang Hisun Pharmaceutical...
Eli Lilly Reports 20% YOY Revenue Growth in Q3 2024 Driven by Mounjaro and Zepbound
US pharmaceutical giant Eli Lilly and Company (NYSE: LLY) has reported its financial results for...
AstraZeneca China President Leon Wang Involved in Chinese Investigation Amid Industry Probes
Leon Wang, Executive Vice President International and AstraZeneca (AZ, NASDAQ: AZN) China President, is cooperating...
AbbVie’s Allergan Aesthetics Launches Juvéderm VOLUX in China
Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), has announced the official market launch of...
Jiangsu Yuyue Medical Equipment Partners with TÜV SUD to Boost Medical Device Market Access
Jiangsu Yuyue Medical Equipment Inc., (SHE: 002223), a Chinese medical equipment manufacturer, has entered into...
GSK Reports Mixed Q3 2024 Results with 2% YOY Revenue Growth
UK pharmaceutical giant GlaxoSmithKline (GSK; NYSE: GSK) has released its financial report for the third...
Allmed Medical Products to Establish Wholly Owned Subsidiary in Indonesia
China-based Allmed Medical Products Co., Ltd (SHE: 002950) has announced plans to establish a wholly...
Sichuan Kelun-Biotech’s Sacituzumab Tirumotecan Files for New Indication with China’s NMPA
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (HKG: 6990) has announced that the National Medical Products Administration...
Akeso Biopharma Initiates Phase III Clinical Trial for PD-1/VEGF Bispecific Antibody Combination
China-based Akeso Biopharma (HKG: 9926) has announced the enrollment of the first patient in a...